Advertisement Engineering mAbs to Enhance Drugability - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Engineering mAbs to Enhance Drugability

CASE STUDIES
By

In this manuscript, Malvern Panalytical compares the stability of three different engineered antibodies as determined by size-exclusion chromatography (SEC) high-performance liquid chromatography (HPLC) analysis during accelerated stability studies, with the stability predicted by differential scanning calligraphy (DSC).

The results demonstrate a correlation between decreased thermostability based on DSC data and greater aggregation formation during accelerated stability studies for the antibodies studied.

The results demonstrate how DSC can be a useful tool in stability screenings of engineered proteins.

Quick Contact


Top Products from